Insider · CIK 0001725539
Jesse E Merten
cfoofficerother
Files at ALL (ALLSTATE CORP). First filing Feb 12, 2025, latest Feb 12, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $7.5M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALL: ALLSTATE CORP
ALLOct 9, 2026 · close 229.43
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | ALLSTATE CORP | $7.5M 40,102 shares | -69% | +3% from low-10% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 3, 2026 | ALL ALLSTATE CORP | MOption exercise Common Stock | +18 | $0.00 | $0 | 32,319 | 6 d ago |
| Oct 3, 2026 | ALL ALLSTATE CORP | FTax withholding Common Stock | -8 | $223.74 | $1,790 | 32,311 | 6 d ago |
| Oct 3, 2026 | ALL ALLSTATE CORP | MOption exercise Restricted Stock Unitsderivative | -18 | $0.00 | $0 | 36 | 6 d ago |
| Feb 24, 2025 | ALL ALLSTATE CORP | AGrant or award Restricted Stock Unitsderivative | +3,603 | $0.00 | $0 | 3,603 | Feb 26, 2025 |
| Feb 24, 2025 | ALL ALLSTATE CORP | AGrant or award Employee Stock Option (Right to Buy)derivative | +14,013 | $0.00 | $0 | 14,013 | Feb 26, 2025 |
| Feb 21, 2025 | ALL ALLSTATE CORP | MOption exercise Common Stock | +1,507 | $0.00 | $0 | 21,656 | Feb 25, 2025 |
| Feb 21, 2025 | ALL ALLSTATE CORP | FTax withholding Common Stock | -668 | $185.66 | $124k | 20,988 | Feb 25, 2025 |
| Feb 21, 2025 | ALL ALLSTATE CORP | MOption exercise Restricted Stock Unitsderivative | -1,507 | $0.00 | $0 | 3,016 | Feb 25, 2025 |
| Feb 17, 2025 | ALL ALLSTATE CORP | AGrant or award Common Stock | +3,652 | $0.00 | $0 | 21,767 | Feb 19, 2025 |
| Feb 17, 2025 | ALL ALLSTATE CORP | FTax withholding Common Stock | -1,618 | $187.63 | $304k | 20,149 | Feb 19, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | MOption exercise Common Stock10b5-1 | +700 | $100.80 | $71k | 18,815 | Feb 12, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | MOption exercise Common Stock10b5-1 | +19,672 | $124.26 | $2.4M | 38,487 | Feb 12, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | MOption exercise Common Stock10b5-1 | +9,730 | $105.08 | $1.0M | 48,217 | Feb 12, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | MOption exercise Common Stock10b5-1 | +10,000 | $122.64 | $1.2M | 58,217 | Feb 12, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | SOpen-market sale Common Stock10b5-1 | -27,315 | $186.03 | $5.1M | 30,902 | Feb 12, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | SOpen-market sale Common Stock10b5-1 | -8,592 | $187.20 | $1.6M | 22,310 | Feb 12, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | SOpen-market sale Common Stock10b5-1 | -2,654 | $188.14 | $499k | 19,656 | Feb 12, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | SOpen-market sale Common Stock10b5-1 | -1,541 | $188.99 | $291k | 18,115 | Feb 12, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -700 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -19,672 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -9,730 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 10, 2025 | ALL ALLSTATE CORP | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 12,879 | Feb 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.